Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $1 | $0 |
| % Growth | 70.2% | 93.5% | 130.1% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | $0 | $0 |
| % Margin | -3.3% | -6.4% | 5.1% | 3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS | -87.6 | -24.54 | -42.75 | -17.86 |
| % Growth | -257% | 42.6% | -139.4% | – |
| EPS Diluted | -87.6 | -24.54 | -42.75 | -17.86 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -7.2% | -3% | -2.2% | 4.9% |